WASHINGTON, April 22 -- National Institutes of Health has issued a notice called: Prospective Grant of an Exclusive Patent License: Size-Dependent Brain and Lymphatic Distribution of Macromolecular Drug Delivery Platform.
The notice was published in the Federal Register on April 22 by Richard U. Rodriguez, Associate Director, Technology Transfer Center, National Cancer Institute.
Summary: The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patents applications listed in the Supplementary Informationsection of this notice to Sangam Lifesciences, Inc. (Sangam), a company ...